Diagnostic delay in women with tuberous sclerosis complex increases mortality risk

NewsGuard 100/100 Score

Women with tuberous sclerosis complex (TSC) are often misdiagnosed because the condition, commonly recognized in early childhood when it presents with seizures, manifests differently later in life, typically with renal angiomyolipomas - a benign tumor of the kidney - and pulmonary lymphangioleiomyomatosis (LAM) - a rare lung disease that affects almost exclusively women. This diagnostic delay places women with TSC at increased risk for morbidity and mortality. TSC is a genetic disease associated with tumor development in the brain, retina, kidney, skin, heart, and lung.

The findings, released online June 20, 2011 in the Annals of Internal Medicine, suggest that education of primary care providers of the warning signs early could speed early treatment and improve outcomes.

According to Diane Seibert, Ph.D., CRNP, associate professor, Uniformed Services University of the Health Sciences (USU) Graduate School of Nursing, the lead author, "We noticed that some patients had symptoms or skin lesions for years before someone finally 'figured' out their diagnosis. Others did not appear to have enough manifestations to receive a TSC diagnosis until adulthood. Clinicians need to know more about TSC so that they can recognize the disease earlier in life."

The study looked at 45 patients who received a diagnosis of TSC in adulthood, 21 of whom had symptoms of LAM, 19 who had renal angiomyolipomas and 10 who had a history of seizures. Of these 45 patients, 30 met clinical criteria for TSC in childhood that remained undiagnosed for a median of 21.5 years. Another 15 were older than 18 years before they met the clinical criteria for a TSC diagnosis. Patients diagnosed in adulthood and those diagnosed in childhood had similar occurrences of pneumothorax, shortness of breath, hemoptysis, nephrectomy and death.

This study found that women who received a TSC diagnosis in adulthood had minimal morbidity during childhood, but were still at risk for life-threatening pulmonary and renal manifestations.

"When people think of patients with TSC they tend to think about a child with cognitive dysfunction, skin lesions and seizures," said Thomas N. Darling, Ph.D., associate professor of Dermatology, USU, the senior author. "However, some patients with TSC have minimal signs or symptoms in childhood and present later in life. We hope that our paper will increase awareness about this subgroup of patients, resulting in earlier recognition and diagnosis along with better outcomes."

This retrospective study was conducted at the National Institutes of Health Clinical Center in Bethesda, Md.

SOURCE Uniformed Services University of the Health Sciences


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates